Previous 10 | Next 10 |
home / stock / ops:cc / ops:cc news
OpSens to Participate in the Transcatheter Cardiovascular Therapeutics Conference (TCT) in San Francisco October 23 - 26, 2023 Canada NewsWire OpSens Anticipates the Results of the SAFE-TAVI Clinical Study on October 25 O pSens to Host ...
Haemonetics Corporation Announces Definitive Agreement to Acquire OpSens, Inc. PR Newswire Expands Haemonetics' Hospital portfolio with innovative fiber optic sensor technology for interventional cardiology Significant commercial synergies with Haemonetics' exist...
OPSENS SIGNS DEFINITIVE AGREEMENT FOR ITS ACQUISITION BY HAEMONETICS Canada NewsWire All amounts in this press release are in Canadian dollars. QUÉBEC CITY, QC , Oct. 10, 2023 /CNW/ - OpSens Inc. ("OpSens" or the "Corporation") (TSX: OPS) (OTCQX...
OPSENS ANNOUNCES A THIRD CONSECUTIVE QUARTER OF RECORD REVENUES FOR THIRD QUARTER FISCAL 2023 Canada NewsWire Total Revenue up 31% - Medical Sales up 36% - Gross Margin up 780 basis points Conference call on the results today at 11:00 a.m. ET QUEB...
OPSENS TO HOST THIRD QUARTER FISCAL YEAR 2023 FINANCIAL RESULTS CONFERENCE CALL ON THURSDAY JULY 13, 2023 Canada NewsWire Conference call to be conducted at 11:00 am ET QUEBEC CITY , July 6, 2023 /CNW/ - OpSens Inc. ("OpSens" or the "Company") ...
OPSENS ANNOUNCES INCLUSION OF SAVVYWIRE™ IN COMPLETE TAVR STUDY Canada NewsWire QUEBEC CITY , May 10, 2023 /CNW/ - OpSens Inc. ("OpSens" or the "Company") (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company delivering ...
Quebec City, Quebec--(Newsfile Corp. - April 20, 2023) - OpSens (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company delivering innovative solutions based on its proprietary optical technology, will be participating in the 2023 Bloom Burton & Co. Healthcare Investor Confer...
OPSENS ANNOUNCES RECORD REVENUE FOR SECOND QUARTER FISCAL 2023 Canada NewsWire Conference call on the results today at 11:00 a.m. ET QUEBEC CITY , April 13, 2023 /CNW/ - OpSens Inc. ("OpSens" or the "Company") (TSX: OPS) (OTCQX: OPSSF), a med...
OPSENS ANNOUNCES COMPLETION OF ENROLLMENT IN SAFE-TAVI STUDY WITH SAVVYWIRE® IN EUROPE Canada NewsWire QUEBEC CITY , April 11, 2023 /CNW/ - OpSens Inc. ("OpSens" or the "Company") (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focus...
OPSENS TO HOST SECOND QUARTER FISCAL YEAR 2023 FINANCIAL RESULTS CONFERENCE CALL ON THURSDAY APRIL 13, 2023 Canada NewsWire Conference call to be conducted at 11:00 am ET QUEBEC CITY , April 6, 2023 /CNW/ - OpSens Inc. ("OpSens" or the "Company...
News, Short Squeeze, Breakout and More Instantly...
HAEMONETICS COMPLETES ACQUISITION OF OPSENS Canada NewsWire All amounts in this press release are in Canadian dollars. QUÉBEC CITY , Dec. 12, 2023 /CNW/ - OpSens Inc. ("OpSens" or the "Corporation") (TSX: OPS) (OTCQX: OPSSF) , a medical...
OPSENS RECEIVES FINAL ORDER FOR ARRANGEMENT WITH HAEMONETICS Canada NewsWire All amounts in this press release are in Canadian dollars. QUÉBEC CITY , Dec. 8, 2023 /CNW/ - OpSens Inc. ("OpSens" or the "Corporation") (TSX: OPS) (OTCQX: OPSSF)...
OPSENS' SHAREHOLDERS APPROVE ARRANGEMENT WITH HAEMONETICS Canada NewsWire All amounts in this press release are in Canadian dollars. QUÉBEC CITY , Dec. 1, 2023 /CNW/ - OpSens Inc. ("OpSens" or the "Corporation") (TSX: OPS) (OTCQX: OPSSF), a...